Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 5Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 5OTHER 4NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Leiomyoma 5Myoma 3Menorrhagia 3Polyps 1Agnosia 1

Interventions

Paclitaxel 489Carboplatin 435Gemcitabine 394Docetaxel 385Cisplatin 359pembrolizumab 343Bevacizumab 335Nivolumab 261Pemetrexed 242Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Uterine Myomectomy × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01750008 2018-11-20

LUSTOR

Acessa Health, Inc.

Phase NA Completed
51 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01152112 2017-09-13

HOME

Hologic, Inc.

Phase NA Completed
74 enrolled 5 charts

Agnosia, Leiomyoma, Polyps

NCT02819609 2016-06-30

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Quintiles, Inc.

Completed
12,234 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡